Add like
Add dislike
Add to saved papers

Response of Lemna gibba L. to high and environmentally relevant concentrations of ibuprofen: Removal, metabolism and morpho-physiological traits for biomonitoring of emerging contaminants.

The increasing worldwide consumption of pharmaceuticals and personal care products such as ibuprofen (IBU) is leading to the widespread and persistent occurrence of these chemicals and their transformation products in soils and waters. Although at low concentrations, the continuous discharge of these micropollutants and the incomplete removal by the actual wastewater treatments can provoke accumulation in the environment with risks for the trophic chain. Non-target organisms as duckweed can be used for the environmental monitoring of pharmaceutical emerging contaminants. In this work, plants of Lemna gibba L. were exposed to high (0.20 and 1mgL-1 ) and environmentally relevant (0.02mgL-1 ) concentrations of IBU to investigate their removal and metabolization capacity. The main oxidized IBU metabolites in humans (hydroxy-IBU and carboxy-IBU) were determined in the intact plants and in the growth solutions, together with non-destructive physiological parameters and phytotoxic indicators. The IBU uptake increased with the increasing of IBU concentration in the medium, but the relative accumulation of the pharmaceutical and generation of hydroxy-IBU was higher in presence of the lower IBU treatments. Carboxy-IBU was not found in the plant tissue and solutions. The changes observed in growth and photosynthetic performances were not able to induce phyto-toxic effects. Apart from a mean physical-chemical degradation of 8.2%, the IBU removal by plants was highly efficient (89-92.5%) in all the conditions tested, highlighting the role of L. gibba in the biodegradation of emerging contaminants.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app